Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2005
11/14/2005CA2810292A1 Ligand for g-protein coupled receptor fprl2 and uses thereof
11/14/2005CA2504920A1 Ligand for g-protein coupled receptor fprl2 and uses thereof
11/10/2005WO2005106493A1 Diagnostics and therapeutics for diseases associated with g protein-coupled apelin receptor (apj)
11/10/2005WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease
11/10/2005WO2005106039A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
11/10/2005WO2005106016A1 METHOD OF DETECTING Th1 CELL
11/10/2005WO2005106000A1 Use of a gene coding for the c4bp protein ? chain for producing recombinant dimeric proteins
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105987A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 2 (csnk1d iso 2)
11/10/2005WO2005105849A1 Compositions and methods for treating proliferative disorders such as nk-type ldgl
11/10/2005WO2005105848A1 Compositions and methods for enhancing nk cell activity
11/10/2005WO2005105847A2 Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof
11/10/2005WO2005105846A1 Antibody specifically recognizing resin plasticizer compound
11/10/2005WO2005105845A2 Phep, an amino acid permease of staphylococcus aureus
11/10/2005WO2005105844A2 Preparation of scfv antibody fragments
11/10/2005WO2005105841A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105133A2 Methods and compositions for preserving the viability of photoreceptor cells
11/10/2005WO2005104785A2 Methods and compositions for specifically targeting human hepatocellular carcinoma cells
11/10/2005WO2005089503A3 Cd4-igg2 formulations
11/10/2005WO2005080428A3 Anti-epcam immunoglobulins
11/10/2005WO2005070456A3 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
11/10/2005WO2005068503A3 M-csf-specific monoclonal antibody and uses thereof
11/10/2005WO2005066348A3 Interleukin-12 targeted to oncofoetal fibronectin
11/10/2005WO2005059504A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
11/10/2005WO2005052002A3 Single-domain antibodies and uses thereof
11/10/2005WO2005049082A3 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia
11/10/2005WO2005049075A3 Compositions and methods for the treatment of tumor of hematopoietic origin
11/10/2005WO2005045044A3 Use of fibroblast growth factor fragments
11/10/2005WO2004075842A3 Mrp3 genes and uses thereof
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050250934 synthetic peptide conjugate compositions for the treatment of immunoglobulins (IgE)-mediated allergic diseases by active immunization
11/10/2005US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/10/2005US20050250186 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
11/10/2005US20050250185 OGH fusion polypeptides and therapeutic uses thereof
11/10/2005US20050250184 Peptide hormones zalpha48 and zsig97
11/10/2005US20050250167 Purified pkb ser 473 kinase and uses thereof
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050250126 Ztnf13, a tumor necrosis factor
11/10/2005US20050250107 High speed detection, isolation of cells; binding to antibodies; fluorescence classification; purification of antibody from egg yolk
11/10/2005US20050250102 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
11/10/2005US20050249815 Process for producing a plasma protein-containing medicament
11/10/2005US20050249753 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis; A transformant E. coli DH5 alpha /YRC-pCRA9Hv (KCTC 1010BP)
11/10/2005US20050249746 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2005US20050249739 Immunoglobulin for treatment and prevention of severe acute respiratory syndrome and/or coronavirus related disorders
11/10/2005US20050249738 Immunotoxins directed against malignant cells
11/10/2005US20050249737 Dendritic cell potentiation
11/10/2005US20050249736 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/10/2005US20050249735 wherein said anti-TNF alpha antibody competitively inhibits binding of TNF alpha to monoclonal antibody cA2
11/10/2005US20050249734 Cortistatin: neuropeptides, compositions and methods
11/10/2005US20050249733 Mammalian proteases; related reagents
11/10/2005US20050249731 Methods of implating mesenchymal stem cells for tissue repair and formation
11/10/2005US20050249729 Anti-TRAIL-R antibody
11/10/2005US20050249728 Anti-IGF-I receptor antibody
11/10/2005US20050249727 Prevention and treatment of amyloidogenic disease
11/10/2005US20050249726 Useful as therapeutic agent and diagnostic tool for brain tumors which strongly express antigen that is recognized by this antibody
11/10/2005US20050249725 Improving cognitive function of individuals with beta amyloid disfunction utilizing beta amyloid specific immunoglobulin; immunotherapeutics
11/10/2005US20050249723 Fc polypeptides with novel Fc ligand binding sites
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249704 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005DE102004018418A1 Diagnose entzündlicher Darmerkrankungen, insbesondere Colitis ulcerosa Diagnosis of inflammatory bowel diseases, particularly ulcerative colitis
11/10/2005CA2565068A1 Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof
11/10/2005CA2565006A1 System and method for identifying complex patterns of amino acids
11/10/2005CA2564596A1 Phep, an amino acid permease of staphylococcus aureus
11/10/2005CA2564432A1 Human anti-amyloid .beta. peptide antibody and fragment of said antibody
11/10/2005CA2564246A1 Compositions and methods for treating immunoproliferatifs disorders such as nk-type ldgl
11/10/2005CA2564244A1 Compositions and methods for enhancing nk cell activity
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2563064A1 Transgenic animals and uses thereof
11/10/2005CA2562604A1 Preparation of scfv antibody fragments
11/10/2005CA2559809A1 Antibodies against human g-protein chemokine receptor (ccr5) hdgnr10
11/09/2005EP1593691A1 Method of acquiring human monoclonal antibody inhibiting cancer cell proliferation
11/09/2005EP1593690A1 Preparation of ScFv antibody fragments
11/09/2005EP1593393A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases
11/09/2005EP1593392A1 Rabies vaccine
11/09/2005EP1592971A1 A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
11/09/2005EP1592813A2 Assay method for group transfer reactions
11/09/2005EP1592811A2 Methods for monitoring drug activities in vivo
11/09/2005EP1592801A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites
11/09/2005EP1592789A2 Administration of transposon-based vectors to reproductive organs
11/09/2005EP1592777A2 A method for generating high affinity antibodies
11/09/2005EP1592776A2 HIGH AFFINITY ANTI-HUMAN IgE ANTIBODIES
11/09/2005EP1592713A2 Antibodies to c-met for the treatment of cancers
11/09/2005EP1592712A2 Anti-dengue virus antibodies, compositions, methods and uses
11/09/2005EP1592711A1 Human heavy chain antibody expression in filamentous fungi
11/09/2005EP1592457A2 Vitamin receptor binding drug delivery conjugates
11/09/2005EP1592446A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries
11/09/2005EP1592445A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
11/09/2005EP1592440A2 Immunoglobulin formulation and method of preparation thereof
11/09/2005EP1592383A2 Methods for reducing mortality associated with acute myocardial infarction
11/09/2005EP1519740A4 Rapid improvement of cognition in conditions related to a-beta
11/09/2005EP1409727B1 Method for qualitative and/or quantitative detection of cells
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1355930B1 A method for identification, isolation and production of antigens to a specific pathogen
11/09/2005EP1297141B1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
11/09/2005EP1295127B1 Inter-alpha-trypsin as a marker for sepsis
1 ... 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 ... 1494